Learn More
Medchemexpress LLC RPI-1 | 269730-03-2 | MFCD03852474 | 99.3% | 297.31 g·mol⁻¹ | C17H15NO4 | 100 MG

Supplier: Medchemexpress LLC HY101246100MG
RPI-1 is a 2-indolinone small-molecule inhibitor of the RET tyrosine kinase used for laboratory research. It inhibits RET autophosphorylation and downstream signaling (PLCγ, ERK, AKT) in cellular models and has demonstrated antitumor activity. Supplied as a solid or as a solution for use in biochemical and cell-based assays.
- Selective RET tyrosine kinase inhibition in cellular assays.
- Reduces RET phosphorylation and downstream signaling pathways.
- High reported purity suitable for biochemical studies.
- Available in multiple sizes and formats for experimental flexibility.
- Provided with certificate of analysis and safety data documentation.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.